icon Newsflash:

Actor James Ransone, known for his role in ‘The Wire’ dead at 46

Government Shutdown Halts SNAP Benefits 8:00 AM

UPS Cargo Plane Crash in Kentucky Kills 7 2:45 AM

Democrats Gain in 2025 State Elections 10:00 PM

USPTO Stays Open Amid Federal Shutdown 9:30 AM

US–China Reach Rare-Earth Trade Accord 11:15 AM

Clocks “Fall Back” as Daylight Saving Time Ends 2:00 AM

Federal Government Shutdown Surpasses Historic Milestone12:01 AM

Insurtech Firm to Release Q3 Results 5:00 PM

“Make-or-Break Day” for Million's Finances 12:00 AM

SpaceX Prepares for next-icon Starship Launch 10:14 am

Julio Rodríguez Can Fly. Will His Bat Ground Him? 10:11 am

SpaceX Prepares for next-icon Starship Launch 10:14 am

icon

Author: Reid Ashton


Reid Ashton

Reid Ashton

Reid Ashton is a health news writer in the U.S. who writes about new medical policies, public health trends, and major scientific breakthroughs. He writes about new ideas in healthcare, the FDA's decisions, and policy changes that affect patients, hospitals, and doctors all throughout the country. His reporting brings us correct, research-based information regarding new diseases, progress in biotechnology, and the future of public health in the US.


Raising Twins With Profound Autism as Calls Grow for New Diagnosis

Raising Twins With Profound Autism as Calls Grow for New Diagnosis

A family raising twins with profound autism shares their daily challenges as experts and advocates debate creating a separate diagnosis for severe autism.

iconFeb 17

by Reid Ashton


A girls soccer tournament drives HPV vaccine awareness in Zimbabwe

A girls soccer tournament drives HPV vaccine awareness in Zimbabwe

A girls’ soccer tournament in Zimbabwe promotes HPV vaccine awareness, using sport to educate young players and communities about preventing cervical cancer.

iconJan 26

by Reid Ashton


FDA Unveils New Approval Pathway for Personalized Therapies

FDA Unveils New Approval Pathway for Personalized Therapies

FDA launches a new regulatory pathway to approve personalized gene and cell therapies using smaller patient data sets, accelerating access for rare diseases and unmet medical needs.

iconNov 12

by Reid Ashton